| 0 (0%) | 06-28 18:07 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 64.38 | 1-year : | 67.07 |
| Resists | First : | 55.12 | Second : | 57.43 |
| Pivot price | 54.15 |
|||
| Supports | First : | 51.38 | Second : | 42.75 |
| MAs | MA(5) : | 52.24 |
MA(20) : | 54.03  |
| MA(100) : | 53.18 |
MA(250) : | 57.81 |
|
| MACD | MACD : | -0.3 |
Signal : | 0.1 |
| %K %D | K(14,3) : | 19.6 |
D(3) : | 15.8 |
| RSI | RSI(14): 43.1 |
|||
| 52-week | High : | 71.25 | Low : | 47.9 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ NTR ] has closed above bottom band by 24.1%. Bollinger Bands are 39.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 52.81 - 53.08 | 53.08 - 53.29 |
| Low: | 51.27 - 51.55 | 51.55 - 51.77 |
| Close: | 51.85 - 52.33 | 52.33 - 52.69 |
Thu, 17 Aug 2023
The DECON pilot project investigates predictive markers for successful bariatric surgery | Scientific Reports - Nature.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 495 (M) |
| Shares Float | 494 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 68.4 (%) |
| Shares Short | 4,700 (K) |
| Shares Short P.Month | 2,450 (K) |
| EPS | 2.52 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 50.86 |
| Profit Margin | 4.4 % |
| Operating Margin | 6.8 % |
| Return on Assets (ttm) | 4.1 % |
| Return on Equity (ttm) | 5 % |
| Qtrly Rev. Growth | -25.9 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 56.77 |
| EBITDA (p.s.) | 10.77 |
| Qtrly Earnings Growth | -83.9 % |
| Operating Cash Flow | 5,070 (M) |
| Levered Free Cash Flow | 1,640 (M) |
| PE Ratio | 20.67 |
| PEG Ratio | -0.6 |
| Price to Book value | 1.02 |
| Price to Sales | 0.92 |
| Price to Cash Flow | 5.1 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|